NSAIDs counteract H. pylori VacA toxin-induced cell vacuolation in MKN 28 gastric mucosal cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 283, Issue 3 46-3, 2002, Pages

  Ricci, Vittorio ^a,c   Manzo, Barbara A ^a,b,c,d,e   Tuccillo, Concetta ^a,b,c,d,e   Boquet, Patrice ^a,b,c,d,e   Ventura, Ulderico ^a,b,c,d,e   Romano, Marco ^a,b,c,d,e   Zarrilli, Raffaele ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d INSERM   (France)

^e Istituto di Fisiologia Umana   (Italy)

Author keywords

Aspirin; Chloride channel blockers; Cyclooxygenases; Indomethacin; NS 398

Indexed keywords

5 NITRO 2 (3 PHENYLPROPYLAMINO)BENZOIC ACID; ACETYLSALICYLIC ACID; AMMONIA; BACTERIAL TOXIN; CHLORIDE CHANNEL BLOCKING AGENT; DIPHTHERIA TOXIN; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; RICIN; UNCLASSIFIED DRUG; VACUOLATING TOXIN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL VIRULENCE; CELL PROLIFERATION; CELL VACUOLE; CONTROLLED STUDY; CYTOTOXICITY; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; INTERNALIZATION; PEPTIC ULCER; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN BINDING; STOMACH MUCOSA; STOMACH MUCOSA LESION;

EID: 0036721518     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00046.2002     Document Type: Article

References (60)

1. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: A case-control study
2. The role of mucus in the protection of the gastroduodenal mucosa
3. The clinical relevance of strain types of Helicobacter pylori
4. Randomised trial of eradication of Helicobacter pylori before nonsteroidal anti-inflammatory drug therapy to prevent peptic ulcers
5. Understanding the mode of action of diphtheria toxin: A perspective on progress during the 20th century
6. Purification and characterization of the vacuolating toxin from Helicobacter pylori
7. Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin
8. Effects of ATPase inhibitors on the response of HeLa cells to Helicobacter pylori vacuolating toxin
9. Potentiation of Helicobacter pylori vacuolating toxin activity by nicotine and other weak bases
10. Helicobacter pylori exotoxins and gastroduodenal diseases associated with cytotoxic strain infection
11. Epithelial cytotoxicity, immune responses, and inflammatory components of Helicobacter pylori gastritis
12. Gastroduodenal mucosal defense mechanisms and the action of non-steroidal anti-inflammatory agents
13. Binding and internalization of Helicobacter pylori vacuolating cytotoxin by epithelial cells
14. ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells
15. Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance
16. Randomised controlled trial of Helicobacter pylori eradication in patients on nonsteroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention
17. Prostaglandin prevents aspirin injury in the canine stomach under in vivo but not in vitro conditions
18. Establishment of cultured lines of human stomach cancer. Origin and their morphological characteristics
19. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs
20. Aspirin-induced gastric mucosal injury: Lessons learned from animal models
21. Helicobacter pylori infection and the development of gastric and duodenal ulcer in arthritic patients receiving chronic NSAIDs therapy
22. Effects of nonsteroidal anti-inflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: Apoptosis, cell proliferation, and inflammatory activity
23. Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans
24. Bacterial lipopolysaccaride protects gastric mucosa against acute injury in rats by activation of genes for cyclooxygenases and endogenous prostaglandins
25. A randomised trial comparing the effect of rofecoxib, a cyclooxygenase-2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
26. Review article: Helicobacter pylori and NSAID gastropathy
27. Apical endocytosis of ricin in MDCK cells is regulated by the cyclooxygenase pathway
28. Protein measurement with Folin phenol reagent
29. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
30. Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells
31. Inhibition of coated pit formation in HEp-2 cells blocks the cytotoxicity of diphtheria toxin but not that of ricin toxin
32. Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances
33. 16,16-Dimethyl prostaglandin E2 protects gastric mucosal surface epithelial cells from indomethacin-induced damage in rats
34. Ricin
35. Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells
36. Cellular vacuoles induces by Helicobacter pylori originate from late endosomal compartments
37. In search of the Helicobacter pylori VacA mechanism of action
38. Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease
39. Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: Role of VacA and CagA
40. High cell sensitivity to Helicobacter pylori VacA toxin depends on a GPI-anchored protein and is not blocked by inhibition of the clathrin-mediated pathway of endocytosis
41. Cytotoxicity of Helicobacter pylori on human gastric epithelial cells in vitro: Role of cytotoxin(s) and ammonia
42. Helicobacter pylori vacuolating toxin accumulates into the endosomal-vacuolar compartment of cultured gastric cells and potentiates the vacuolating activity of ammonia
43. The vacuolating toxin of Helicobacterpylori: A few answers, many questions
44. Voyage of Helicobacter pylori in human stomach: Odyssey of a bacterium
45. Human cell line for study of damage to gastric epithelial cells in vitro
46. 2 synthesis in MKN 28 gastric mucosal cells in vitro
47. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection
48. Persistence of Helicobacter pylori VacA toxin and vacuolating potential in cultured gastric epithelial cells
49. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity
50. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease
51. The Helicobacter pylori VacA toxin is a urea permease that promotes urea diffusion across epithelia
52. Inhibition of the vacuolating and anion channel activities of the VacA toxin of Helicobacter pylori
53. Campylobacter-like organisms and surface epithelium abnormalities in active, chronic gastritis in humans: An ultrastructural study
54. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastro-intestinal toxicity
55. Gastroduodenal mucosal defense
56. Anti-thrombotic effects of a nitric oxide-releasing, gastric-sparing aspirin derivative
57. Prostaglandin endoperoxide synthase: Why two isoforms?
58. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
59. Molecular response of gastric epithelial cells to Helicobacter pylori-induced cell damage
60. Nonsteroidal anti-inflammatory drugs could reverse to Helicobacter pylori-induced apoptosis and proliferation in gastric epithelial cells